We have isolated and characterized a clone (100-10) of the murine T-cell lymphoma S49 line with an altered AMP deaminase (EC 18.104.22.168-AMP aminohydrolase) activity. The 100-10 clone was isolated in suspension culture by continuous selection in medium containing arabinosyl 2,6-diaminopurine followed by cloning in semisolid agarose containing arabinosyl diaminopurine. The 100-10 cell line, compared to the wild type cell line, is characterized by an increased growth sensitivity to adenine and to adenosine in the presence of the adenosine deaminase inhibitor, erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA), and reduced sensitivity to thymidine, deoxyadenosine (plus EHNA), arabinosyl diaminopurine, arabinosyl guanine, and arabinosyl adenine (plus EHNA). The complex growth phenotype of the 100-10 cells is the consequence of two separate mutations. The 100-10 cells have an AMP deaminase with altered kinetic properties which can account for the increased sensitivity to growth inhibition by adenine or adenosine and for a reduced flux of nucleotides from AMP to IMP and GTP. The altered enzyme in the mutant cell line has a lower V(max), a higher K(m) for AMP, increased sensitivity to inhibition by inorganic phosphate, and a 10-fold higher K(i) for GTP. The 100-10 cells also possess a ribonucleotide reductase activity with decreased sensitivity to feedback inhibition by deoxyATP. This accounts for the resistance of the 100-10 cell line to 2'-deoxyribose- and arabinose-containing purines. The independence of the two mutations has been demonstrated by isolating from 100-10 cells an adenosine-resistant revertant clone.
|Original language||English (US)|
|Number of pages||8|
|Journal||Journal of Biological Chemistry|
|State||Published - 1981|
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology